Skip to main content
Clinical Trials/CTRI/2017/10/010132
CTRI/2017/10/010132
Recruiting
未知

Population Pharmacokinetic and Pharmacodynamic study of Caffeine and Aminophylline in Apnea of prematurity - AOP, PKPD, AGA, SGA

Science and Engineering Research Board0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Premature neonates with apnea of prematurityHealth Condition 2: P073- Preterm [premature] newborn [other]
Sponsor
Science and Engineering Research Board
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Science and Engineering Research Board

Eligibility Criteria

Inclusion Criteria

  • Preterms (\<\= 34wk gestation) with \> 6 apneic episodes within 24hr of life, who will be receiving Methylxanthines for AOP.

Exclusion Criteria

  • Congenital anomalies, secondary causes of apnea (sepsis, significant Patent Ductus Arteriosus, Glucose, electrolytes abnormality), receiving drugs with enzyme inducing or inhibiting property, previously receiving Methylxanthine.

Outcomes

Primary Outcomes

Not specified

Similar Trials